Evogene annual gross profit
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Evogene Gross Profit Growth & History (EVGN)
Evogene's gross profit was −$241,000 for fiscal 2025.
View full Evogene company overviewEvogene annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$241,000 | −$3.4M | — |
| 2024 | 2024-12-31 | $3.2M | $1.7M | +114.28% |
| 2023 | 2023-12-31 | $1.5M | $726,000 | +94.78% |
| 2022 | 2022-12-31 | $766,000 | $603,000 | +369.94% |
| 2021 | 2021-12-31 | $163,000 | −$303,000 | −65.02% |
| 2020 | 2020-12-31 | $466,000 | $47,000 | +11.22% |
| 2019 | 2019-12-31 | $419,000 | $124,000 | +42.03% |
| 2018 | 2018-12-31 | $295,000 | −$241,000 | −44.96% |
| 2017 | 2017-12-31 | $536,000 | −$365,000 | −40.51% |
| 2016 | 2016-12-31 | $901,000 | −$2.0M | −68.65% |
| 2015 | 2015-12-31 | $2.9M | — | — |
Evogene gross profit trends
Over the last five fiscal years, Evogene's gross profit decreased from $466,000 to −$241,000, a change of −$707,000.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evogene source filings ↗